Behavioral and neurochemical effects induced by reserpine in mice.

Author: BusanelloAlcindo, CerettaAna Paula Chiapinotto, FachinettoRoselei, KrumBárbara Nunes, LealCaroline Queiroz, PerozaLuis Ricardo, SchafferLarissa Finger, da RochaJoão Batista Teixeira, de FreitasCatiuscia Molz

Paper Details 
Original Abstract of the Article :
RATIONALE: Reserpine, a monoamine-depleting agent, which irreversibly and non-selectively blocks the vesicular monoamine transporter, has been used as an animal model to study several neurological disorders, including tardive dyskinesia and Parkinson's disease. OBJECTIVE: The purpose of this study ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1007/s00213-015-4118-4

データ提供:米国国立医学図書館(NLM)

Investigating the Neurochemical Effects of Reserpine in Mice

Reserpine, a drug that depletes monoamines (chemicals that act as neurotransmitters in the brain), has been used as a model to study various neurological disorders such as tardive dyskinesia and Parkinson's disease. This study aims to investigate the motor deficits induced by reserpine in mice by examining changes in the expression of dopaminergic system proteins, including tyrosine hydroxylase (TH) and dopamine transporter (DAT), as well as the activity of monoamine oxidase (MAO). The researchers administered different doses of reserpine to mice for four consecutive days and evaluated their behavior and neurochemical changes at various time points after drug withdrawal.

Reserpine's Impact on Dopaminergic System and Behavior

The study found that reserpine administration led to increased vacuous chewing movements (VCMs) and decreased locomotion in mice. These behavioral changes were accompanied by a reduction in TH immunoreactivity in the striatum, a brain region crucial for movement control. Interestingly, negative correlations were observed between VCMs and MAO-A or MAO-B activity, as well as TH striatal immunoreactivity. On the other hand, a positive correlation was found between VCMs and DAT immunoreactivity in the substantia nigra, another brain region involved in movement regulation.

Understanding the Role of Reserpine in Neurochemical Disorders

This research provides valuable insights into the neurochemical and behavioral alterations caused by reserpine. It suggests that the blockade of the vesicular monoamine transporter (VMAT) by reserpine can disrupt the balance of neurotransmitters in the brain, leading to motor deficits and other neurological changes. This study underscores the importance of understanding the complex interplay between neurochemicals and behavior, particularly in the context of neurological disorders.

Dr.Camel's Conclusion

This research is like a camel caravan journeying through a desert of neurochemicals, exploring the complex landscape of the brain. Reserpine’s effects, while initially used to study neurological disorders, reveal a fascinating interplay between neurotransmitters and behavior. It’s like discovering a hidden oasis in the desert - a reminder that even in seemingly barren landscapes, there’s always something new to discover.

Date :
  1. Date Completed 2016-08-29
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

26514557

DOI: Digital Object Identifier

10.1007/s00213-015-4118-4

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.